Lumbar injection: corticosteroids vs stem cells and the fear of oxycodone
A patient with chronic lower back pain refuses a corticosteroid injection and seeks stem cell therapy. The debate highlights the fear of oxycodone and the available alternatives.
English · Original discussion in Spanish · Published
The lumbar injection dilemma: corticosteroids, stem cells and the antiestéticar of oxycodone
A patient with chronic lower back pain faces a complex medical decision: accepting the epidural corticosteroid injection offered by Spain's public health system, or seeking regenerative alternatives such as stem cells, which the system rules out. The pain unit doctor's refusal to refer him for surgery and the increase of his oxycodone dose from 5 to 10 mg without full relief add urgency to the case.
The proposed treatment: epidural corticosteroids
Epidural corticosteroid injections are the standard treatment for lumbar radicular pain, but their long-term effectiveness is limited. The patient sees it as "a patch" to get back to work, not a solution. Moreover, the doctor warned him that stem cells are useless because "the nerve endings are so damaged they would not regenerate." With no public health coverage for that treatment, corticosteroids are the only option available through the public system.
Alternatives on the table
Among the suggestions in the debate, the McKenzie physiotherapy method stands out, which has worked in similar cases without risks, as well as hierba oil as a palliative option. However, the patient's priority is to know whether anyone with a similar condition has had a successful injection. A consultation with a private orthopedic surgeon on Monday could open the door to surgery, although the pain unit doctor declined to give an opinion.
The antiestéticar of oxycodone —a powerful opioid— leads the patient to ration it, taking it only when the pain leaves him incapacitated, even though the dose has been doubled. This pattern of intermittent use can worsen pain control.
The situation reflects the limitations of the public health system when it comes to regenerative treatments, the reluctance toward surgery, and the difficult balance between opioids and quality of life. The outcome will depend on the private orthopedic surgeon's opinion.
Related forum discussions
A patient with chronic lower back pain faces a complex medical decision: accepting the epidural corticosteroid injection offered by Spain's public health system, or seeking regenerative alternatives such as stem cells, which the system rules out. The pain unit doctor's refusal to refer him for surgery and the increase of his oxycodone dose from 5 to 10 mg without full relief add urgency to the case.
The proposed treatment: epidural corticosteroids
Epidural corticosteroid injections are the standard treatment for lumbar radicular pain, but their long-term effectiveness is limited. The patient sees it as "a patch" to get back to work, not a solution. Moreover, the doctor warned him that stem cells are useless because "the nerve endings are so damaged they would not regenerate." With no public health coverage for that treatment, corticosteroids are the only option available through the public system.
Alternatives on the table
Among the suggestions in the debate, the McKenzie physiotherapy method stands out, which has worked in similar cases without risks, as well as hierba oil as a palliative option. However, the patient's priority is to know whether anyone with a similar condition has had a successful injection. A consultation with a private orthopedic surgeon on Monday could open the door to surgery, although the pain unit doctor declined to give an opinion.
The antiestéticar of oxycodone —a powerful opioid— leads the patient to ration it, taking it only when the pain leaves him incapacitated, even though the dose has been doubled. This pattern of intermittent use can worsen pain control.
The situation reflects the limitations of the public health system when it comes to regenerative treatments, the reluctance toward surgery, and the difficult balance between opioids and quality of life. The outcome will depend on the private orthopedic surgeon's opinion.
Related forum discussions
- Esta galería tiene 25 AÑOS. GRAN RESERVA 2001. De mi FELPUTECA PERSONAL. INENCONTRABLE. · 42 replies
- ¿Cuál creéis que será mi próxima caja? · 58 replies
- EXTREME DERROITION: os presento a MEGAULTRAFELPUPIZPI DERROYER PREMIUM DESTROYER TURBO 2000 PAULA de AbbyWinters · 217 replies
- Hilo del real madrid 2025/26. año i después de modric y cesard. el advenimiento de franco. · 84137 replies
Also available in: Deutsch
Summary of a discussion on Burbuja.info - Foro de economía, actualidad y política., translated from Spanish and reviewed before publication. Read the full discussion (13 replies).
More summaries
-
Back Pain: From Personal Complaint to Gender Crusade
A patient recounts how the examination of his back pain complaint devolved into an issue concerning gender.
-
Kidney Stones and Toothache: The Real Pain Scale
Kidney stones and toothaches top the intense pain scale; rheumatism and plantar fasciitis win for duration. The gap in delayed pain relief.
-
The TV shows nobody remembers anymore: from 'Bla, bla, bla' to 'Suspiros de España'
From 'Bla, bla, bla' to 'Jazz entre amigos': the television nobody remembers anymore. Prime time started at 21:35 and the broadcast day closed with the national anthem.
-
Crespo Family: Balancing Local Politics with Digital Business
The Crespo family combines local governance with digital entrepreneurship. We analyze the tension between rural life, subsidies, and their online content impact.
-
When Grandma Dies, the Family Often Drifts Apart
The saying "When grandma dies, the family dies" describes how the matriarch's death sometimes coincides with siblings drifting apart. Is it causation or mere coincidence?
-
Barça 2026/27: 33 goals in 7 games and the shadow of the Cucurella deal
Flick's Barça open the 2026/27 season with 33 goals in 7 games while debate rages over Real Madrid's signing of Cucurella.